Transgenic mice overexpressing a constitutively active form of GSK-3β were shown to reduce the cardiac hypertrophy induced by the activation of calcineurin, β-adrenergic stimulation, and pressure overload (26). This evidence concerns the gene GSK3B and cardiac hypertrophy.